Finance

Beta
Lists
PRE:NASDAQ
Prenetics Global Ltd
$18.58
-1.33%
(-0.25) 1D
Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
$18.59
High
$19.32
Low
$18.21
Mkt. cap
318.53M
Avg. vol.
262.60K
Volume
0.00
52-wk high
$23.63
52-wk low
$7.18
EPS
-$3.30
Beta
0.30
Shares outstanding
15.56M
No. of employees
98
Open
$18.59
High
$19.32
Low
$18.21
Mkt. cap
318.53M
Avg. vol.
262.60K
Volume
0.00
52-wk high
$23.63
52-wk low
$7.18
EPS
-$3.30
Beta
0.30
Shares outstanding
15.56M
No. of employees
98
News stories
From sources across the web
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees98
Founded2014
Headquarters-
SectorHealth care provider
Websiteprenetics.com
Analyst ratings
Based on 2 analysts giving stock ratings to PRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current $18.58
$36.00 (+93.76%)
Average
$33.00 (+77.61%)
Lowest
$30.00 (+61.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Bill Sutherland
Benchmark Co.
Buy
Initiated
$30.00
+61.5%
06/16/2026
George Kelly
Roth MKM
Buy
Reiterated
$36.00
+93.8%
05/15/2026
Ryan Meyers
Lake Street
Buy
Initiated
$29.00
+56.1%
03/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
14.96M
23.56M
36.56M
35.95M
Cost of goods sold
9.13M
9.53M
14.97M
12.67M
Cost of revenue
9.13M
9.53M
14.97M
12.67M
Research and development expenses
803.00K
1.17M
743.00K
1.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.52M
19.41M
34.13M
31.55M
Operating expense
13.52M
20.19M
35.17M
32.15M
Total operating expenses
22.65M
29.72M
50.14M
44.82M
Operating income
-7.68M
-6.16M
-13.58M
-8.87M
Other non operating income
-637.00K
96.00K
9.59M
-17.86M
EBT including unusual items
-8.70M
-6.78M
-9.66M
-27.31M
EBT excluding unusual items
-8.60M
-6.78M
-3.87M
-26.74M
Income tax expense
51.00K
9.00K
38.00K
28.00K
Effective tax rate
-0.59%
-0.13%
-0.39%
-0.10%
Other operating expenses
194.00K
-395.00K
297.00K
-840.00K
Net income
-12.41M
-7.41M
-7.50M
-23.10M
Net profit margin
-82.93%
-31.45%
-20.52%
-64.26%
Earnings per share
-
-
-0.19
-
Interest and investment income
731.00K
-
1.20M
-
Interest expense
-72.00K
-55.00K
-45.00K
-9.00K
Net interest expenses
659.00K
-55.00K
1.15M
-9.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.75M
-5.33M
-13.34M
-8.71M
Gain or loss from assets sale
-
-
-
-253.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer